IGF1 and steatosis: Next, we evaluated whether, in addition to the benefits in terms of APT, glycogen and phospholipids induced by the lipid treatment in steatotic livers, changes in growth factors (HGF, IGF1 and VEGFA) could explain the enhanced benefits conferred by the lipid treatment in the presence of steatosis.